Back to search results

Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab

Abroad (travel likely)RecruitingPHASE2

Conditions

Diabetes Mellitus, Type 1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

    Contact: Study coordinator (Yulia V Tikhonovich, M.D.) · tikhonovich_yu_v@staff.sechenov.ru · +79163266210
    Contact: Study coordinator (Tatiana E Ivannikova, M.D.) · ivannikova_t_e@staff.sechenov.ru · +79166564245
    Contact: Principal Investigator (Yulia V Tikhonovich, M.D.)
    Tatiana E Ivannikova, M.D. (Sub-investigator)

  • Russian Children's Clinical Hospital, Pirogov Russian National Research Medical University, Moscow, Russia

    Contact: Study coordinator (Elena E Petryaykina, M.D.) · director@rdkb.ru · +74959369251
    Contact: Study coordinator (Alexei V Timofeev, Ph.D.) · alvaltim@gmail.com · +79161608994
    Contact: Principal Investigator (Elena S Demina, M.D.)
    Sergey A Lukyanov, Ph.D., D.Sc. (Sub-investigator)
    Alexei V Timofeev, Ph.D. (Sub-investigator)
    George V Sharonov, Ph.D. (Sub-investigator)
    Yevgeniya A Kolesnikova, Ph.D. (Sub-investigator)
    Ruslan R Galimov (Sub-investigator)
Study leads

  • Dmitry M Chudakov, Ph.D., D.Sc.

    Study Chair

    Institute of Translational medicine, Pirogov Russian National Research Medical University

  • Elena E Petryaykina, M.D.

    Study Director

    Russian Children's Clinical Hospital, Pirogov Russian National Research Medical University

  • Elena S Demina, M.D.

    Principal Investigator

    Russian Children's Clinical Hospital, Pirogov Russian National Research Medical University

View source on ClinicalTrials.gov(opens in a new tab)